Olistico Wealth’s Gilead Sciences GILD Stock Holding History

Olistico Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-51	Closed	-$5.65K	–	185
2025 Q2	$5.65K	Buy	+51	New	+$5.43K	﹤0.01%	286

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Olistico Wealth's GILD Position: Q3 2025 in Review

Olistico Wealth sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 51 shares — an estimated $5.65K sold.

Olistico Wealth first reported a position in GILD in Q2 2025 and held it in 1 quarter. The position peaked at $5.65K in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Olistico Wealth reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Olistico Wealth sold 51 Gilead Sciences shares in Q3 2025, an estimated $5.65K.
Olistico Wealth first reported a position in Gilead Sciences in Q2 2025 and held it in 1 quarter.
Olistico Wealth's Gilead Sciences position peaked at $5.65K in Q2 2025.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Olistico Wealth's 13F filing for Q3 2025, filed 24 Oct 2025.